Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
View Press ReleaseStevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
View Press ReleaseStevanato Group to Participate in Upcoming Investor Conferences
View Press ReleaseStevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025
View Press Release
Quarter Ended Jun 30, 2025
For Fiscal Year Ending Dec 31, 2024
Sign up today and receive company updates straight to your inbox.
Stevanato Group S.p.A.
Via Molinella 17
Piombino Dese, Padua 35017
Italy
Lisa Miles
Chief Communications and Investor Relations Officer
lisa.miles@stevanatogroup.com
Giacomo Guiducci
Strategic Marketing and Investor Relations
giacomo.guiducci@stevanatogroup.com
Team Lewis U.S.
T: +1 872 264 2546
stevanatous@teamlewis.com
Team Lewis Italy
T: +39 02 36531375
stevanatoita@teamlewis.com